RedChip Companies
|
|
Weekly Newsletter
|
|
|
Digital Ally: Diversified Holdings with Multiple Growth Opportunities
|
Digital Ally’s (Nasdaq: DGLY) diversified holdings, which generated 191% revenue growth YoY in the first nine months of 2022, provide multiple growth opportunities. The Company’s acquisition of new business lines and its evolution from hardware-focused sales to a subscription-based model for its legacy video technology solutions business over the past 24 months have been key drivers for its rapid growth. Importantly, to maximize value for its diverse operations, Digital Ally intends to spin-off its ticketing and entertainment business, TicketSmarter into a separate public company in 2023. TicketSmarter has more than 48 million tickets for sale and is an official ticketing partner of Spartan Races, Professional Fighters League, Country Roots Festival, and more. Watch our recent interview with DGLY Chairman and CEO Stan Ross to learn more.
For more information, visit www.digitalallyinc.com
|
Zomedica Reports 2022 Revenue Up 361% to $18.9 Million Revenue with 72% Gross Margin & $156 Million in Liquidity
Zomedica (NYSE American: ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, reported fiscal 2022 results with revenue up 361% to $18.9 million. Commenting on this impressive performance, Zomedica CEO Larry Heaton said, “At Zomedica we're bringing products to Veterinarians to help them do the things they really LOVE to do - improve the quality of care for the pets and the satisfaction of the pet parents; and to help them do the things they really NEED to do - improve workflow, cashflow and profitability. 2022 was another transformational year for Zomedica through acquisitions of products that meet this standard, along with significant improvements in infrastructure, manufacturing capacity, and commercial capabilities.”
|
Encouraging Efficacy Data in BioVie’s Ascites Phase 2b Trial Leads to Pause in Patient Enrollment and Initiation of FDA Discussions to Conduct Pivotal Registrational Trial
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced encouraging efficacy data from the first 15 patients in its Phase 2b study. “Compelling data from the first 15 patients led us to pause enrollment,” commented Cuong Do, BioVie’s President and CEO. “Given the high unmet need for this condition, we believe the most prudent course is to initiate conversations with the FDA on proceeding to the pivotal Phase 3 trial so that we can bring this innovation to patients as quickly as possible.”
|
|
|
Sidus Space Names 40+ Year Industry Veteran Richard Kube as Chief Production Officer
Sidus Space (Nasdaq: SIDU), a Space-as-a-Service company focused on mission critical hardware manufacturing combined with commercial satellite design, manufacture, launch, and data collection, appointed Richard Kube to the role of Chief Production Officer (CPO). With over 40 years of experience in the engineering, manufacturing and aerospace industries, Rich brings a wealth of knowledge to Sidus Space.
|
ASP Isotopes Announces Letter to Stockholders
ASP Isotope (Nasdaq: ASPI), an advanced materials company dedicated to the development of technology and processes designed to produce isotopes used in multiple industries, announced a letter to stockholders from Chairman and CEO Paul Mann highlighting the Company’s recent accomplishments and upcoming milestones.
|
|
|
Upcoming Events |
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| 4:15pm Eastern |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
|
| NASDAQ: IINN - Inspira Technologies |
| 11:00am Eastern |
| Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
|
| NASDAQ: BFRG - BullFrog AI |
| 11:00am Eastern |
| BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. |
|
|
|
|
|
| OTCQB: QYOUF - QYOU Media |
| 4:15pm Eastern |
| QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
|
| NASDAQ: SIDU - Sidus Space |
| 4:15pm Eastern |
| Sidus Space Inc is a Space-as-a-Service company focused on commercial satellite design, manufacture, launch, and data collection with a vision to enable space flight heritage status for new technologies and deliver data and predictive analytics to both domestic and global customers. |
|
|
|
|
|
| NASDAQ: IINN - Inspira Technologies |
| 11:00am Eastern |
| Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
|
| OTC: EBZT - Everything Blockchain |
| 4:15pm Eastern |
| Everything Blockchain is a development, engineering, and services company specializing in Blockchain technologies and decentralized processing. The Company works with clients to develop custom Blockchain payment solutions settled in fiat and cryptocurrencies. |
|
|
|
|
|
| NASDAQ: STSS - Sharps Technology |
| 4:15pm Eastern |
| Sharps Technology is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. |
|
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| 4:15pm Eastern |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
Archive Events |
|
|
|
|
| NASDAQ: BIVI - BioVie |
| Meeting Duration 45 minutes |
| BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
|
| NYSE American: GNS - Genius Group |
| Meeting Duration 66 minutes |
| Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
|
| NASDAQ: IMNM - Immunome |
| Meeting Duration 37 minutes |
| Immunome was founded to advance the discovery and development of antibody-based drugs. Our proprietary antibody Discovery Engine identifies novel therapeutic antibodies, and their antigen targets, by leveraging the most highly-educated components of the B cells from patients who have learned to fight off their disease. |
|
|
|
|
|
| NASDAQ: IINN - Inspira Technologies |
| Meeting Duration 35 minutes |
| Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
|
| NASDAQ: ASPI - ASP Isotopes |
| Meeting Duration 23 minutes |
| ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
|
| OTCQB: AMNI - American Noble Gas |
| Meeting Duration 16 minutes |
| American Noble Gas Inc is active in the energy sector. It has conducted an environmental study and developed geological information from the reprocessing and additional evaluation of existing two-dimensional (2-D) seismic data in the Perlas and Tyra concession blocks. |
|
|
|
|
|
| NASDAQ: RCRT - Recruiter.com |
| Meeting Duration 44 minutes |
| Recruiter.com is an on-demand recruiting platform providing flexible talent acquisition solutions that scale from startups to the Fortune 100. |
|
|
|
|
|
| NYSE American: GNS - Genius Group |
| Meeting Duration 74 minutes |
| Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
|
| NASDAQ: KWE - KWESST Micro Systems |
| Meeting Duration 38 minutes |
| KWESST Micro Systems develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. |
|
|
|
|
|
| NASDAQ: GENE - Genetic Technologies Limited |
| Meeting Duration 28 minutes |
| Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
|
| NASDAQ: ARDS - Aridis Pharmaceuticals |
| Meeting Duration 62 minutes |
| Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
Lesson of the Week
Compare a stock's value to its peers to determine relative value.
|
|
|
MidSouth Week in Review
The Federal Reserve is expected to hike rates next week, despite shaky banks. The yield on the 5-year Treasury bonds declined from 4.4% to 3.6%.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
|
© 2023 RedChip , All rights reserved
|
|
| |
|
|
